-+ 0.00%
-+ 0.00%
-+ 0.00%

TYRA BIOSCIENCES, - ANNOUNCES INITIAL PHASE 2 SURF302 RESULTS FOR ORAL DABOGRATINIB

Reuters·09/09/2026 11:00:10

Please log in to view news